Moliya
Moliya
Bosh sahifaDVA • NYSE
Davita Inc
151,85 $
Seans yopilganidan keyin:
151,85 $
(0,00%)0,00
Yopilgan:24-apr, 17:57:32 (GMT-4) · USD · NYSE · Ogohlantirish
AksiyalarAQSH qimmatli qogʻoziBosh shtabi: AQSH
Yopilish kursi
155,03 $
Kunlik diapazon
149,99 $ - 154,45 $
Yillik diapazon
101,00 $ - 159,42 $
Bozor kapitalizatsiyasi
10,01 mlrd USD
Oʻrtacha hajm
797,21 ming
Narx/foyda
15,96
Dividend daromadliligi
-
Asosiy maydon
NYSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(USD)dek, 2025Y/Y qiyosi
Daromad
3,62 mlrd9,87%
Joriy xarajat
659,06 mln11,97%
Sof foyda
234,22 mln-9,68%
Sof foyda marjasi
6,47-17,79%
Har bir ulushga tushum
3,4051,79%
EBITDA
737,91 mln12,69%
Amaldagi soliq stavkasi
20,05%
Jami aktivlari
Jami passivlari
(USD)dek, 2025Y/Y qiyosi
Naqd pul va qisqa investitsiyalar
700,74 mln-17,17%
Jami aktivlari
17,48 mlrd1,13%
Jami passivlari
16,32 mlrd7,42%
Umumiy kapital
1,16 mlrd
Tarqatilgan aksiyalar
66,80 mln
Narxi/balansdagi bahosi
-16,32
Aktivlardan daromad
7,87%
Kapitaldan daromad
9,79%
Naqd pulning sof oʻzgarishi
(USD)dek, 2025Y/Y qiyosi
Sof foyda
234,22 mln-9,68%
Operatsiyalardan naqd pul
540,73 mln-1,26%
Sarmoyadan naqd pul
-163,13 mln34,22%
Moliyadan naqd pul
-414,52 mln26,65%
Naqd pulning sof oʻzgarishi
-37,67 mln86,49%
Boʻsh pul
395,96 mln16,37%
Haqida
DaVita Inc., incorporated in Delaware and headquartered in Denver, provides kidney dialysis services through a network of 2,657 outpatient centers in the United States, serving 200,500 patients, and 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation. In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the Fortune 500. Wikipedia
Tashkil etilgan
1992
Xodimlar soni
78 000
Yana
Bu sizni qiziqtirishi mumkin
Bu roʻyxat oxirgi qidiruvlar, kuzatilgan aksiyalar va boshqa faoliyatdan tuzilgan. Batafsil

Barcha axborotlar faqat maʼlumot sifatida “shundayligicha” taqdim etilgan, ulardan moliyaviy maslahat sifatida foydalanmang, ular savdo maqsadlari yoki investitsiya, soliq, yuridik, buxgalteriya yoki boshqa turdagi maslahat emas. Google investitsiya borasida maslahatchi emas, bu roʻyxatdagi kompaniyalar yoki ularning aksiyalari borasida hech qanday nuqtai nazar, tavsiya yoki fikr bildirmaydi. Har qanday savdoni boshlashdan oldin broker yoki moliyaviy vakil bilan maslahatlashib, narxlarni tekshiring. Batafsil
Aloqador qidiruvlar
Qidiruv
Qidiruv maydonini tozalash
Qidiruvni yopish
Google ilovalari
Asosiy menyu